Myomo Inc
AMEX:MYO
Balance Sheet
Balance Sheet Decomposition
Myomo Inc
Current Assets | 32.8m |
Cash & Short-Term Investments | 24.9m |
Receivables | 3.8m |
Other Current Assets | 4.1m |
Non-Current Assets | 9.5m |
PP&E | 8.9m |
Other Non-Current Assets | 539.4k |
Balance Sheet
Myomo Inc
Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
1
|
1
|
13
|
7
|
4
|
12
|
16
|
5
|
7
|
24
|
|
Cash Equivalents |
1
|
1
|
13
|
7
|
4
|
12
|
16
|
5
|
7
|
24
|
|
Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
|
Total Receivables |
0
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
2
|
4
|
|
Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
2
|
4
|
|
Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Inventory |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
3
|
|
Other Current Assets |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
Total Current Assets |
1
|
1
|
14
|
8
|
6
|
14
|
19
|
9
|
14
|
33
|
|
PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
9
|
|
PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
9
|
|
Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
Total Assets |
2
N/A
|
2
+10%
|
14
+743%
|
8
-41%
|
7
-20%
|
15
+123%
|
20
+37%
|
10
-49%
|
15
+43%
|
42
+190%
|
|
Liabilities | |||||||||||
Accounts Payable |
0
|
1
|
1
|
0
|
0
|
0
|
1
|
1
|
2
|
3
|
|
Accrued Liabilities |
0
|
0
|
0
|
1
|
1
|
3
|
3
|
2
|
3
|
6
|
|
Short-Term Debt |
1
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
|
Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Current Liabilities |
1
|
3
|
1
|
2
|
4
|
3
|
4
|
4
|
5
|
10
|
|
Long-Term Debt |
1
|
3
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
|
Total Liabilities |
3
N/A
|
7
+129%
|
2
-77%
|
2
+21%
|
5
+157%
|
3
-34%
|
5
+49%
|
4
-19%
|
6
+47%
|
18
+213%
|
|
Equity | |||||||||||
Common Stock |
13
|
13
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Retained Earnings |
19
|
23
|
35
|
45
|
56
|
68
|
78
|
89
|
97
|
103
|
|
Additional Paid In Capital |
5
|
5
|
47
|
52
|
58
|
79
|
94
|
95
|
106
|
128
|
|
Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Equity |
1
N/A
|
5
-263%
|
12
N/A
|
6
-48%
|
2
-72%
|
12
+534%
|
15
+33%
|
6
-59%
|
9
+41%
|
25
+175%
|
|
Total Liabilities & Equity |
2
N/A
|
2
+10%
|
14
+743%
|
8
-41%
|
7
-20%
|
15
+123%
|
20
+37%
|
10
-49%
|
15
+43%
|
42
+190%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
0
|
0
|
0
|
0
|
1
|
5
|
7
|
8
|
27
|
34
|